NCT04269707View on ClinicalTrials.gov

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

PHASE3CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

January 29, 2021

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferric carboxymaltose

IV iron

Trial Locations (2)

33155

Miami Clinical Research, Miami

33166

South Florida Research Phase I-IV, Miami Springs

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY

NCT04269707 - Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044 | Biotech Hunter | Biotech Hunter